Empasug -M 500/5

Empagliflozin 5mg + Metformin 500mg is a fixed-dose combination oral tablet used for the treatment of type 2 diabetes mellitus. This formulation combines two effective antidiabetic agents with complementary mechanisms of action:

• Empagliflozin (5mg): A Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor that lowers blood sugar by increasing the excretion of glucose through the urine.

• Metformin (500mg): A biguanide that decreases hepatic glucose production and improves insulin sensitivity, thereby reducing blood glucose levels.

Together, these medicines work synergistically to improve glycemic control, reduce blood sugar levels, and support weight management. This combination is particularly beneficial for patients who require better glucose control than metformin alone, while also providing cardiovascular benefits associated with Empagliflozin.